{"log_id": 5912364348695424273, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 6e-06, "average": 0.994435, "min": 0.992074}, "location": {"width": 91, "top": 376, "height": 27, "left": 358}, "words": "急诊治疗"}, {"probability": {"variance": 2e-06, "average": 0.996724, "min": 0.994735}, "location": {"width": 93, "top": 422, "height": 29, "left": 358}, "words": "皮肤反应"}, {"probability": {"variance": 0.028616, "average": 0.895884, "min": 0.379266}, "location": {"width": 950, "top": 468, "height": 43, "left": 360}, "words": " NSAIDS,包括本可能引起致命的.严重的肤不良反应,例如剥说性皮炎,SIS和TEN。这些"}, {"probability": {"variance": 0.016722, "average": 0.93189, "min": 0.405438}, "location": {"width": 954, "top": 511, "height": 45, "left": 356}, "words": "严重件可在没有征兆的情况下出现,应告知患者重皮肤反应的症状和体征,在第一次出现皮"}, {"probability": {"variance": 0.012469, "average": 0.942291, "min": 0.634772}, "location": {"width": 454, "top": 561, "height": 29, "left": 358}, "words": "肤皮疹或过敏反应的其他征象时,应停用木"}, {"probability": {"variance": 7.5e-05, "average": 0.99415, "min": 0.979224}, "location": {"width": 98, "top": 605, "height": 29, "left": 354}, "words": "注意事项"}, {"probability": {"variance": 0.025138, "average": 0.882223, "min": 0.494229}, "location": {"width": 625, "top": 653, "height": 31, "left": 356}, "words": "近免与其它非体抗炎药,包括选择性cOx-2抑制剂合井用药"}, {"probability": {"variance": 0.007683, "average": 0.944696, "min": 0.661196}, "location": {"width": 868, "top": 696, "height": 41, "left": 354}, "words": "根据控伟状的需要,在最短治疗时间内使用最低有效剂量可以使不良反应降到最任"}, {"probability": {"variance": 0.01494, "average": 0.938885, "min": 0.375293}, "location": {"width": 705, "top": 742, "height": 38, "left": 356}, "words": "本品的致癌性试验尚完成,积用约时间暂限定在24周内(含24周"}, {"probability": {"variance": 0.028562, "average": 0.882957, "min": 0.380269}, "location": {"width": 957, "top": 788, "height": 43, "left": 351}, "words": "通常:本品不能用于替代皮质类固醇激索或治疗皮质类固醇激缺乏,骤停用皮质类激素"}, {"probability": {"variance": 0.021025, "average": 0.916014, "min": 0.375287}, "location": {"width": 941, "top": 831, "height": 50, "left": 347}, "words": "会导致需皮质类固醇素控制的疾病的恶化,长期使用皮质炎固醉激素治疗的患者如决定停药"}, {"probability": {"variance": 0.071489, "average": 0.734593, "min": 0.368172}, "location": {"width": 134, "top": 884, "height": 27, "left": 354}, "words": "则应减量"}, {"probability": {"variance": 0.00797, "average": 0.949848, "min": 0.705852}, "location": {"width": 952, "top": 927, "height": 47, "left": 356}, "words": "程定非感染性疼疗与感染合并存在时,本品减轻炎症和缓发热的药理学特性会减弱这些阳性体"}, {"probability": {"variance": 0.008517, "average": 0.938926, "min": 0.696125}, "location": {"width": 230, "top": 977, "height": 29, "left": 351}, "words": "征在诊断感染上的价值"}, {"probability": {"variance": 0.008654, "average": 0.951868, "min": 0.74475}, "location": {"width": 137, "top": 1025, "height": 29, "left": 358}, "words": "对肝脏的影响"}, {"probability": {"variance": 0.016408, "average": 0.928234, "min": 0.543561}, "location": {"width": 799, "top": 1069, "height": 45, "left": 354}, "words": "本品尚未在肝功能不全的患者中进行相大研究。故不建议肝功能不全的愿者使用"}, {"probability": {"variance": 0.013103, "average": 0.922936, "min": 0.579253}, "location": {"width": 941, "top": 1117, "height": 47, "left": 358}, "words": "在关于 NSAIDS的临床研究中,多至159服用的患者会有一项多项肝实验室指标的临界增高"}, {"probability": {"variance": 0.021455, "average": 0.927024, "min": 0.367364}, "location": {"width": 941, "top": 1165, "height": 45, "left": 358}, "words": "有1%的思者会出现显著的ALTAST的升高高于正常值上限的三倍或更多倍)。继续治疗,"}, {"probability": {"variance": 0.015493, "average": 0.920874, "min": 0.487697}, "location": {"width": 984, "top": 1210, "height": 45, "left": 299}, "words": "么这些实验室异常值可能过展、保持稳定恢复正常。在 NSAID,包括塞米苷布胶囊的治疗中"}, {"probability": {"variance": 0.037569, "average": 0.882377, "min": 0.35585}, "location": {"width": 1021, "top": 1254, "height": 54, "left": 280}, "words": "怀有的严重反应的报道,包括黄疸型和致命的暴发型肝炎,肝坏死和F功能〔有些会"}, {"probability": {"variance": 0.02992, "average": 0.896294, "min": 0.360633}, "location": {"width": 868, "top": 1306, "height": 45, "left": 436}, "words": "若本品的患者有提示肝脏功能不全的症状和或体征,或有肝功能不全的实验证"}, {"probability": {"variance": 0.040439, "average": 0.863063, "min": 0.363953}, "location": {"width": 968, "top": 1354, "height": 50, "left": 310}, "words": "量脏功能恶化发展的证据若症状和体征均提示肝班疾病进展或有全牙表现如"}, {"probability": {"variance": 0.031492, "average": 0.863772, "min": 0.481277}, "location": {"width": 342, "top": 1402, "height": 31, "left": 404}, "words": "胞增多症。皮等)。应停用本品"}, {"probability": {"variance": 0.022966, "average": 0.920221, "min": 0.530483}, "location": {"width": 187, "top": 1448, "height": 31, "left": 347}, "words": "对血液系统的影响"}, {"probability": {"variance": 0.014954, "average": 0.926149, "min": 0.548931}, "location": {"width": 934, "top": 1494, "height": 47, "left": 347}, "words": "本品临床研究中思者出现货血,据文献报道使用塞来昔布胶囊治疗的患者中有时会出现贫血"}, {"probability": {"variance": 0.019712, "average": 0.915773, "min": 0.444209}, "location": {"width": 929, "top": 1542, "height": 45, "left": 351}, "words": "长应用本品的忌者如果出现任何贫血或失血的症状和体征,应该检查血红蛋白和血细胞比容"}, {"probability": {"variance": 0.046746, "average": 0.84165, "min": 0.535937}, "location": {"width": 93, "top": 1594, "height": 27, "left": 351}, "words": "伴有音"}, {"probability": {"variance": 0.01571, "average": 0.928786, "min": 0.494951}, "location": {"width": 954, "top": 1638, "height": 45, "left": 349}, "words": "哮喘者可能因阿司匹林过敏面诱发哮喘。有阿司匹林诱发哮喘的忠者使用阿司匹林会导致严重"}, {"probability": {"variance": 0.021963, "average": 0.918578, "min": 0.358445}, "location": {"width": 952, "top": 1685, "height": 43, "left": 347}, "words": "的可能命的支气管挛。由于这些阿司匹林过敏的患名中阿司匹林和其它非体类抗炎药物之"}, {"probability": {"variance": 0.013643, "average": 0.944877, "min": 0.435574}, "location": {"width": 954, "top": 1731, "height": 45, "left": 347}, "words": "间的交叉反应包括支气管痉挛已有报故本品不应用于此类型的阿司匹林过敏者,在伴有"}, {"probability": {"variance": 0.017246, "average": 0.924492, "min": 0.611492}, "location": {"width": 324, "top": 1781, "height": 29, "left": 347}, "words": "哮喘的患者中用本品也要谨慎"}, {"probability": {"variance": 8.1e-05, "average": 0.98917, "min": 0.978238}, "location": {"width": 95, "top": 1827, "height": 27, "left": 347}, "words": "患者须知"}, {"probability": {"variance": 0.034088, "average": 0.91182, "min": 0.39257}, "location": {"width": 571, "top": 1873, "height": 38, "left": 347}, "words": "在开始本品治疗前治疗过程中应定告知患者以下信息"}, {"probability": {"variance": 0.010566, "average": 0.949051, "min": 0.542388}, "location": {"width": 957, "top": 1919, "height": 47, "left": 344}, "words": "1.本品与其它 NSAIDS一样,可能引起严重的心血管不良反应,例如心肌梗死或率中,这些不良"}], "language": 3}